Lithuania is one of the partners of this project. The project aims to develop an AI-driven platform that assists healthcare professionals in creating personalised testing, tracing, and treatment plans for patients with precancerous stomach conditions, ultimately helping to prevent the progression to stomach cancer.
Name in original language
-
Initiative overview
AIDA is a four-year Horizon Europe project (Grant 101095359; ~€7 million incl. UKRI support) coordinated by INCLIVA (Spain) to develop and validate an AI assistant for gastric-cancer prevention. The consortium brings together 12 centres of excellence from 8 countries, including the University of Latvia and the Hospital of Lithuanian University of Health Sciences Kaunas Clinics. The workplan targets a deployable solution—with certification as a medical device—covering diagnosis of precancerous gastric inflammation, personalised therapy selection and follow-up monitoring.
Name of responsible organisation (in English)
UL Institute of Clinical and Preventive Medicine
